Skip to main content
. 2013 Apr;15(4):435–447. doi: 10.1593/neo.122132

Table 1.

Patient Information.

Sample ID Chip ID Genetic Backgr. Sex Age at Surgery Age at First Presentation Age at Dgn. Loc. Status MA qRT-PCR
01M/01C PKh_03* dna m 61.0 dna dna dna dna x 01M1
02M/02C PKh_04* dna nk nk dna dna dna dna x 02M*
03M/03C PKh_05* dna f 53.0 dna dna dna dna x 03M*,†
04-1M/04-1C PKh_06* dna f 72.0 dna dna dna dna x 04-1M*
04-2M/04-2C PKh_07* dna f 72.0 dna dna dna dna x 04-2M*
05M/05C PKh_42* dna m 65.0 dna dna dna dna x
06M/06C PKh_43* dna m 56.0 dna dna dna dna x
07M/07C PKh_44* dna m 62.0 dna dna dna dna x
08B PKh_40 SDHB f 30.0 27 30 A Pr-NM x
09B PKh_10 SDHB m 28.5 12 29 E Met x
10B PKh_11 SDHB m 24.0 20 23 E Pr-M x
11B PKh_13 SDHB f 46.0 28 46 A Pr-NM x
12B PKh_18 SDHB f 9.0 8 9 E Mlt-NM x x
13B PKh_19 SDHBP m 22.8 15–16 22 E Pr-M x
14B PKh_20 SDHB m 26.6 8 9 E Met x x
15B PKh_21 SDHB m 38.2 37 38 E Pr-M x
16B PKh_22 SDHB f 45.6 41 42 E Mlt-NM x
17-1B PKh_27 SDHB f 36.0 32 33 E Met x x
17-2B PKh_28 SDHB f 36.2 32 33 E Met x
18B PKh_31 SDHB m 52.0 40 41 E Met x
19B PKh_32 SDHB m 12.0 13 13 E Pr-NM x
20B PKh_33 SDHB m 31.0 30 30 E Pr-NM x x
21B PKh_34 SDHB m 55.0 50 53 E Mlt-NM x x
22B PKh_36 SDHB m 35.0 no symptoms 34 E Mlt-NM x
23B PKh_38 SDHB f 34.8 10 18 E Met x
24B PKh_39 SDHB m 17.1 15 15 A Mlt-NM x
25D(HN) PKh_37 SDHD m 24.3 23 23 HN Pr-NM x
26D(HN) PKh_60 SDHD f 34.0 34 34 HN Bi-M x
27D(HN) PKh_01 SDHD f 49.3 28 28 HN Pr-NM x x
28D(HN) PKh_02 SDHD f 61.1 60 60 HN Pr-NM x
29D(AT) PKh_08 SDHD m 16.0 16 16 A Pr-NM x x
30D(AT) PKh_09 SDHD f 31.0 31 31 A Pr-NM x x
31-1D(AT) PKh_24 SDHD f 26.6 23 24 A Mlt-NM x
31-2D(HN) PKh_25 SDHD f 26.6 23 24 HN Mlt-NM x x
31-3D(HN) PKh_29 SDHD f 27.1 23 24 HN Mlt-NM x
32D(HN) PKh_58 SDHD m 48.0 48 48 HN Bi-NM x x
33D(AT) PKh_26 SDHD m 61.4 58 58 A Pr-NM x x
34D(HN) PKh_59 SDHD f 29.0 29 29 HN Mlt-NM x x
35-1D(AT) PKh_35 SDHD m 31.8 31 25 A Mlt-NM x x
35-2D(AT) PKh_41 SDHD m 32.6 31 25 E Mlt-NM x
36V PKh_57 VHL f 24.8 no symptoms 17 A Bi-NM x
37-1V PKh_55 VHL m 22.7 18 22 A Bi/Mlt-NM x
37-2V PKh_56 VHL m 23.1 18 22 A Bi/Mlt-NM x
38V PKh_54 VHL m 16.1 16 16 A Bi/Rec-NM x
39V PKh_53 VHL m 28.6 no symptoms <28 A Pr-NM x
40V PKh_52 VHL m 13.1 no symptoms 12 A Bi-NM x
41V PKh_45 VHL f 42.8 nk <41 A Pr-NM x
42V PKh_46 VHL m 29.4 29 29 A Bi/Mlt-NM x
43V PKh_47 VHL f 42.6 nk <15 A Bi-NM x x
44V PKh_48 VHL m 39.2 nk 39 A Pr-NM x x
45V PKh_49 VHL m 30.6 <30 30 A Bi-NM x
46V PKh_50 VHL m 33.1 4 5 A Bi/Mlt/Rec-NM x x
47V PKh_51 VHL m 18.9 no symptoms 16 A Bi/Mlt-NM x
48V dna VHL m 33.5 nk nk A Bi-NM x

A indicates adrenal; f, female; backgr., background; Bi, bilateral; dgn., diagnosis; dna, does not apply; E, extra-adrenal; ID, identifier; loc., location; m, male; M, metastatic; MA, microarray; met, metastases; Mlt, multifocal primary; nk, not known; NM, non-metastatic; Pr, primary; Rec, recurrent; SDHDP, SDHD-polymorphism; x indicates sample used in experiment specified by column heading; patients 25, 31, and 40 were first-degree relatives to 35, 33, and 47, respectively.

*

Applies to normal medulla samples.

†

Included for ACTR10, EGLN3, F8, LGR5, MPP6, NEFM, SLC18A1, TMEM130, and VSNL1.